04/18/2024 4:23 PM | Intra-Cellular Therapies (Filer)
| Form 424B5 | |
04/18/2024 4:25 PM | Intra-Cellular Therapies (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
04/16/2024 3:40 PM | Intra-Cellular Therapies (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
04/16/2024 3:37 PM | Intra-Cellular Therapies (Filer)
| Form 424B5 | |
04/16/2024 6:10 AM | Intra-Cellular Therapies (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
04/02/2024 3:15 PM | Intra-Cellular Therapies (Issuer) RIGGS RORY B (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
04/02/2024 3:15 PM | Intra-Cellular Therapies (Issuer) VAN NOSTRAND ROBERT L (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
|
04/01/2024 4:15 PM | Intra-Cellular Therapies (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
03/19/2024 7:44 AM | Intra-Cellular Therapies (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
03/11/2024 7:31 PM | Durgam Suresh K. (Reporting) Intra-Cellular Therapies (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/11/2024 7:31 PM | Intra-Cellular Therapies (Issuer) Neumann Mark (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/11/2024 7:32 PM | Halstead Michael (Reporting) Intra-Cellular Therapies (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/11/2024 7:33 PM | Hineline Lawrence J. (Reporting) Intra-Cellular Therapies (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/11/2024 7:33 PM | Intra-Cellular Therapies (Issuer) Mates Sharon (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/11/2024 3:52 PM | Intra-Cellular Therapies (Subject) Neumann Mark (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
03/11/2024 3:38 PM | Hineline Lawrence J. (Reporting) Intra-Cellular Therapies (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
03/11/2024 3:45 PM | Halstead Michael (Reporting) Intra-Cellular Therapies (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
03/11/2024 3:30 PM | Durgam Suresh K. (Reporting) Intra-Cellular Therapies (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
03/11/2024 3:30 PM | Intra-Cellular Therapies (Subject) Mates Sharon (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
03/08/2024 4:58 PM | Durgam Suresh K. (Reporting) Intra-Cellular Therapies (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/08/2024 4:58 PM | Hineline Lawrence J. (Reporting) Intra-Cellular Therapies (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/08/2024 4:58 PM | Halstead Michael (Reporting) Intra-Cellular Therapies (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/08/2024 4:59 PM | Intra-Cellular Therapies (Issuer) Mates Sharon (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/08/2024 4:59 PM | Intra-Cellular Therapies (Issuer) Neumann Mark (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/07/2024 3:44 PM | Intra-Cellular Therapies (Subject) Neumann Mark (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
03/07/2024 3:36 PM | Halstead Michael (Reporting) Intra-Cellular Therapies (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
03/07/2024 3:27 PM | Hineline Lawrence J. (Reporting) Intra-Cellular Therapies (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
03/05/2024 6:04 PM | Durgam Suresh K. (Reporting) Intra-Cellular Therapies (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/05/2024 6:05 PM | Intra-Cellular Therapies (Issuer) Neumann Mark (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/05/2024 6:05 PM | Hineline Lawrence J. (Reporting) Intra-Cellular Therapies (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/05/2024 6:05 PM | Halstead Michael (Reporting) Intra-Cellular Therapies (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/28/2024 6:41 PM | Intra-Cellular Therapies (Issuer) VAN NOSTRAND ROBERT L (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/27/2024 6:57 PM | Intra-Cellular Therapies (Issuer) MARCUS JOEL S (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/27/2024 6:58 PM | Intra-Cellular Therapies (Issuer) Neumann Mark (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/27/2024 6:58 PM | Durgam Suresh K. (Reporting) Intra-Cellular Therapies (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/27/2024 6:59 PM | Intra-Cellular Therapies (Issuer) Mates Sharon (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/27/2024 7:00 PM | Hineline Lawrence J. (Reporting) Intra-Cellular Therapies (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/27/2024 7:00 PM | Halstead Michael (Reporting) Intra-Cellular Therapies (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/27/2024 3:22 PM | Intra-Cellular Therapies (Subject) VAN NOSTRAND ROBERT L (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
02/26/2024 3:46 PM | Halstead Michael (Reporting) Intra-Cellular Therapies (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
02/26/2024 3:46 PM | Durgam Suresh K. (Reporting) Intra-Cellular Therapies (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
Don’t Miss Out on the AI Gold Rush That’s Just Getting Started (Ad) “Titan of Tech” Bets Big on Tiny AI Company
He’s made as much as 3,250,000% in just three years on companies like Facebook, Airbnb, and PayPal…
But our research shows his latest investment could be his most successful venture yet. See how you can invest alongside him |
02/26/2024 3:33 PM | Intra-Cellular Therapies (Subject) Mates Sharon (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
02/26/2024 3:22 PM | Intra-Cellular Therapies (Subject) Neumann Mark (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
02/22/2024 6:39 AM | Intra-Cellular Therapies (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
02/22/2024 6:42 AM | Intra-Cellular Therapies (Filer)
| Form 10-K Annual report pursuant to Section 13 or 15(d) | |
02/09/2024 11:40 AM | Intra-Cellular Therapies (Subject) WASATCH ADVISORS LP (Filed by)
| Form SC 13G/A | |
02/05/2024 5:02 PM | Durgam Suresh K. (Reporting) Intra-Cellular Therapies (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/05/2024 5:05 PM | Hineline Lawrence J. (Reporting) Intra-Cellular Therapies (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/05/2024 5:07 PM | Intra-Cellular Therapies (Issuer) Neumann Mark (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/05/2024 5:10 PM | Intra-Cellular Therapies (Issuer) Mates Sharon (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/05/2024 5:13 PM | Halstead Michael (Reporting) Intra-Cellular Therapies (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/02/2024 3:47 PM | Hineline Lawrence J. (Reporting) Intra-Cellular Therapies (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
02/02/2024 3:39 PM | Durgam Suresh K. (Reporting) Intra-Cellular Therapies (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
02/02/2024 3:41 PM | Intra-Cellular Therapies (Subject) Mates Sharon (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
01/18/2024 6:47 PM | Intra-Cellular Therapies (Issuer) Mates Sharon (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/16/2024 4:08 PM | Intra-Cellular Therapies (Subject) Mates Sharon (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
01/12/2024 5:02 PM | Halstead Michael (Reporting) Intra-Cellular Therapies (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/11/2024 3:45 PM | Halstead Michael (Reporting) Intra-Cellular Therapies (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
01/04/2024 6:54 PM | Durgam Suresh K. (Reporting) Intra-Cellular Therapies (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/03/2024 5:43 PM | Intra-Cellular Therapies (Issuer) VAN NOSTRAND ROBERT L (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/03/2024 5:46 PM | Intra-Cellular Therapies (Issuer) RIGGS RORY B (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/02/2024 3:38 PM | Durgam Suresh K. (Reporting) Intra-Cellular Therapies (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
12/13/2023 10:15 AM | Durgam Suresh K. (Reporting) Intra-Cellular Therapies (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
12/01/2023 3:52 PM | Alexandria Venture Investments, LLC (Reporting) Intra-Cellular Therapies (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
11/08/2023 4:31 PM | Intra-Cellular Therapies (Issuer) Neumann Mark (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
11/06/2023 3:15 PM | Alexandria Venture Investments, LLC (Reporting) Intra-Cellular Therapies (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
11/06/2023 12:06 PM | Intra-Cellular Therapies (Subject) Neumann Mark (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
11/02/2023 7:01 AM | Intra-Cellular Therapies (Filer)
| Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
11/02/2023 7:01 AM | Intra-Cellular Therapies (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
10/02/2023 4:29 PM | Intra-Cellular Therapies (Issuer) RIGGS RORY B (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
10/02/2023 4:30 PM | Intra-Cellular Therapies (Issuer) VAN NOSTRAND ROBERT L (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
09/19/2023 7:40 PM | Intra-Cellular Therapies (Issuer) Mates Sharon (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
09/19/2023 3:13 PM | Intra-Cellular Therapies (Subject) Mates Sharon (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
09/18/2023 3:13 PM | Intra-Cellular Therapies (Subject) Mates Sharon (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
09/13/2023 3:18 PM | Alexandria Venture Investments, LLC (Reporting) Intra-Cellular Therapies (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
08/14/2023 3:40 PM | Alexandria Venture Investments, LLC (Reporting) Intra-Cellular Therapies (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
08/09/2023 5:05 PM | Intra-Cellular Therapies (Issuer) Neumann Mark (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
08/07/2023 5:09 PM | Intra-Cellular Therapies (Subject) Neumann Mark (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
08/03/2023 6:39 AM | Intra-Cellular Therapies (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
08/03/2023 6:44 AM | Intra-Cellular Therapies (Filer)
| Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
07/20/2023 4:47 PM | Durgam Suresh K. (Reporting) Intra-Cellular Therapies (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
07/17/2023 3:13 PM | Durgam Suresh K. (Reporting) Intra-Cellular Therapies (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
07/07/2023 5:07 PM | Hineline Lawrence J. (Reporting) Intra-Cellular Therapies (Issuer)
| Form 4/A | |
07/07/2023 5:07 PM | Halstead Michael (Reporting) Intra-Cellular Therapies (Issuer)
| Form 4/A | |
07/07/2023 5:08 PM | Intra-Cellular Therapies (Issuer) Mates Sharon (Reporting)
| Form 4/A | |
07/05/2023 3:30 PM | Intra-Cellular Therapies (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
07/05/2023 3:30 PM | Intra-Cellular Therapies (Issuer) RIGGS RORY B (Reporting) RIGGS RORY B (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/27/2023 4:11 PM | Intra-Cellular Therapies (Issuer) MARCUS JOEL S (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/27/2023 4:11 PM | Intra-Cellular Therapies (Issuer) RIGGS RORY B (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/27/2023 4:12 PM | Intra-Cellular Therapies (Issuer) Salas Eduardo Rene (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/27/2023 4:12 PM | Intra-Cellular Therapies (Issuer) VAN NOSTRAND ROBERT L (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
Pentagon contract could send this $2 AI stock soaring (Ad) Whenever the Department of Defense awards a major AI contract...
Early investors could see dramatic returns virtually overnight.
That's how my readers were able to cash in gains like 133% in just four months on C3.ai... Get all the info here >>> |
06/16/2023 4:05 PM | Hineline Lawrence J. (Reporting) Intra-Cellular Therapies (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/14/2023 3:28 PM | Hineline Lawrence J. (Reporting) Intra-Cellular Therapies (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
05/04/2023 6:45 AM | Intra-Cellular Therapies (Filer)
| Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
05/04/2023 6:37 AM | Intra-Cellular Therapies (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |